z-logo
HomeZAIABlog
open-access-imgOpen Access
The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?
Author(s) -
Younossi Zobair M.
Publication year - 2015
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.514
Subject(s) - ribavirin , medicine , pegylated interferon , cirrhosis , hepatitis c , hepatitis c virus , viral load , intensive care medicine , virus , immunology
Watch a video presentation of this article Watch the interview with the author

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.